Suppr超能文献

肾病综合征的分子机制概述。

An overview of molecular mechanism of nephrotic syndrome.

作者信息

Machado Juliana Reis, Rocha Laura Penna, Neves Precil Diego Miranda de Menezes, Cobô Eliângela de Castro, Silva Marcos Vinícius, Castellano Lúcio Roberto, Corrêa Rosana Rosa Miranda, Reis Marlene Antônia

机构信息

Pathology Laboratory, Department of Biological Sciences, Federal University of Triângulo Mineiro, 38025-180 Uberaba, MG, Brazil.

出版信息

Int J Nephrol. 2012;2012:937623. doi: 10.1155/2012/937623. Epub 2012 Jul 11.

Abstract

Podocytopathies (minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS)) together with membranous nephropathy are the main causes of nephrotic syndrome. Some changes on the expression of nephrin, podocin, TGF-β, and slit diaphragm components as well as transcription factors and transmembrane proteins have been demonstrated in podocytopathies. Considering the pathogenesis of proteinuria, some elucidations have been directed towards the involvement of epithelial-mesenchymal transition. Moreover, the usefulness of some markers such as TGF-β1, nephrin, synaptopodin, dystroglycans, and malondialdehyde have been determined in the differentiation between MCD and FSGS. Experimental models and human samples indicated an essential role of autoantibodies in membranous glomerulonephritis, kidney damage, and proteinuria events. Megalin and phospholipase-A2-receptor have been described as antigens responsible for the formation of the subepithelial immune complexes and renal disease occurrence. In addition, the complement system seems to play a key role in basal membrane damage and in the development of proteinuria in membranous nephropathy. This paper focuses on the common molecular changes involved in the development of nephrotic proteinuria.

摘要

足细胞病(微小病变病(MCD)和局灶节段性肾小球硬化症(FSGS))与膜性肾病一起是肾病综合征的主要病因。在足细胞病中已证实肾足突蛋白、足动蛋白、转化生长因子-β(TGF-β)、裂孔隔膜成分以及转录因子和跨膜蛋白的表达存在一些变化。考虑到蛋白尿的发病机制,一些解释指向了上皮-间质转化的参与。此外,已确定一些标志物如TGF-β1、肾足突蛋白、突触素、抗肌萎缩蛋白聚糖和丙二醛在MCD和FSGS的鉴别诊断中的作用。实验模型和人类样本表明自身抗体在膜性肾小球肾炎、肾损伤和蛋白尿事件中起重要作用。巨膜蛋白和磷脂酶A2受体已被描述为负责形成上皮下免疫复合物和引发肾脏疾病的抗原。此外,补体系统似乎在膜性肾病的基底膜损伤和蛋白尿的发生发展中起关键作用。本文重点关注肾病性蛋白尿发生发展过程中涉及的常见分子变化。

相似文献

1
An overview of molecular mechanism of nephrotic syndrome.肾病综合征的分子机制概述。
Int J Nephrol. 2012;2012:937623. doi: 10.1155/2012/937623. Epub 2012 Jul 11.
8
Pathogenic Role of MicroRNA Dysregulation in Podocytopathies.微小RNA失调在足细胞病中的致病作用
Front Physiol. 2022 Jun 29;13:948094. doi: 10.3389/fphys.2022.948094. eCollection 2022.

引用本文的文献

9
Minimal change nephrotic syndrome and prohibitin-2 gene polymorphism.微小病变型肾病综合征与抑制素-2基因多态性
Clin Exp Nephrol. 2017 Aug;21(4):665-670. doi: 10.1007/s10157-016-1325-1. Epub 2016 Nov 4.

本文引用的文献

1
C4d as a diagnostic tool in membranous nephropathy.C4d 作为膜性肾病的诊断工具。
Nefrologia. 2012 May 14;32(3):295-9. doi: 10.3265/Nefrologia.pre2012.Feb.11224.
3
Advances in membranous nephropathy: success stories of a long journey.膜性肾病的进展:漫长征程中的成功故事。
Clin Exp Pharmacol Physiol. 2011 Jul;38(7):460-6. doi: 10.1111/j.1440-1681.2011.05506.x.
4
Experimental Models of Membranous Nephropathy.膜性肾病的实验模型
Drug Discov Today Dis Models. 2010 Spring;7(1-2):27-33. doi: 10.1016/j.ddmod.2010.11.001.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验